Project: Saliva- and blood-based lung cancer detection based on tumour auto-antibody profiling
| Acronym | PROFILUX (Reference Number: 113654) |
| Duration | 01/04/2020 - 01/10/2023 |
| Project Topic | We will deliver a novel minimally-invasive in vitro diagnostic (IVD) test for the early detection of lung cancer (LC), based on a set of proprietary tumour-associated autoantibody biomarkers (TAAs) discovered in European and East-Asian lung cancer populations. We will select final candidate markers, develop a multiplex diagnostic assay, perform an independent analytical validation, and carry out a first clinical verification on independent European and East-Asian blood/saliva samples. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 12 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Asan Medical Center | Partner | Korea, Republic of |
| 2 | Austrian Institute of Technology GmbH | Partner | Austria |
| 3 | Datamedrix GmbH | Partner | Austria |
| 4 | InSol Co., Ltd. | Coordinator | Korea, Republic of |
| 5 | Protein Alternatives, S.L. | Partner | Spain |